CSE/OVAT (CSE/OVAT)

Canadian Securities Exchange: CSE/OVAT · CAD

CA$0.03

+0.01 (+50.0%)· Recorded snapshot

Market cap	1.2M
Revenue (ttm)	57.3K
Net income (ttm)	-657.4K
EPS (ttm)	-CA$0.02
Shares out	38.4M
Volume	5,650
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57.3K
Net income (ttm): -657.4K
EPS (ttm): -CA$0.02
Market cap: 1.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/OVAT indicators

Market & fundamental data

Available fields

152

Groups with data

Currency

CAD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-20
Enterprise value	CAD 1.4M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2017
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA69016D1087
Last earnings date	2025-11-27
Last refreshed	2026-10-29
Market cap	CAD 1.2M
Next earnings date	2026-11-20
Price	CAD 0.03
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-09-23
Symbol	cse/OVAT
Website	https://ovationscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-58.7%
EV/Sales	24.98x
FCF / EV yield	-9.64%
FCF yield	-11.98%
Industry forward P/E	34.4x
P/S ratio	20.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	51.7%
Operating margin	-1,102.1%
Pretax margin	-1,146.42%
ROA	-1,210.23%
ROA (5Y)	-323.29%
ROCE	35.28%
SBC / revenue	119.38%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-49.16%
Gross profit growth (Q)	-50.78%
Gross profit growth 3Y	-35.3%
Gross profit growth 5Y	-39.32%
Net income growth years	0
Revenue growth	-11.38%
Revenue growth (Q)	-50.82%
Revenue growth (QoQ)	-46.97%
Revenue growth 3Y	-20.19%
Revenue growth 5Y	-34.38%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -631,990
EPS	CAD -0.02
FCF per share	CAD -0.00
Financing cash flow	CAD 146,481
Free cash flow	CAD -138,125
Free cash flow minus SBC	CAD -206,580
Gross profit	CAD 29,645
Net cash flow	CAD 7,670
Net income	CAD -657,404
Operating cash flow minus SBC	CAD -206,580
Operating income	CAD -631,990
Revenue	CAD 57,344
Stock-based compensation	CAD 68,455

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-595.5
Book value per share	CAD -0.05
Interest coverage	-17.32
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD -278,927
Net cash / market cap	-24.19%
Piotroski F-Score	2
Shareholders' equity	CAD -1.8M
Tangible book value	CAD -1.8M
Tangible book value per share	CAD -0.05
Total assets	CAD 25,711
Total cash	CAD 13,217
Total debt	CAD 292,144
Total liabilities	CAD 1.8M
WACC	7.94%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.76
Current assets	CAD 25,711
Current liabilities	CAD 1.8M
Current ratio	0.01
Net working capital	CAD -1.5M
Quick ratio	0.01
Working capital	CAD -1.8M
Working capital turnover	-0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.2%
Shareholder yield	1.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.04
1D price change	50%
1W price change	50%
1W total return	50%
1Y price change	-25%
1Y return CAGR	-25.01%
1Y total return	-25%
20-day SMA	CAD 0.03
200-day SMA	CAD 0.04
3M price change	100%
3M total return	100%
3Y price change	20%
3Y return CAGR	6.26%
3Y total return	20%
50-day SMA	CAD 0.03
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.05
52-week high date	2025-11-28
52-week low	CAD 0.02
52-week low date	2026-06-01
5Y price change	-71.43%
5Y return CAGR	-22.17%
5Y total return	-71.43%
All-time high	CAD 0.65
All-time high date	2019-05-08
All-time low	CAD 0.01
All-time low date	2023-04-28
Average true range (ATR)	CAD 0.00
Average volume	19.3K
Beta (1Y)	1.29
Beta (2Y)	1.2
Beta (5Y)	0.58
Change from 52-week high	-40%
Change from 52-week low	100%
Change from all-time high	-95.38%
Change from all-time low	200%
Change from open	0%
Day's gap	50%
Dollar volume	CAD 170
High price	CAD 0.03
Low price	CAD 0.03
Monthly RSI	46.73
Open price	CAD 0.03
Previous close	CAD 0.02
Price vs 150-day SMA	-17.81%
Price vs 20-day SMA	20%
Price vs 200-day SMA	-17.81%
Price vs 50-day SMA	-6.83%
Relative volume	0.29
RSI	52.91
Sharpe ratio	1.8
Sharpe ratio (3Y)	0.88
Sortino ratio	3.55
Sortino ratio (3Y)	1.63
Volume	5.7K
Weekly RSI	45.53
YTD price change	-25%
YTD total return	-25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33.2M
Shares change (QoQ)	0%
Shares change (YoY)	-1.2%
Shares held by insiders	13.51%
Shares outstanding	38.4M

Deeper analysis on CSE/OVAT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/OVAT report

Is a complete CSE/OVAT research report available?

No complete published report is available for cse/OVAT (CSE/OVAT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/OVAT (CSE/OVAT)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/OVAT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/OVAT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/OVAT

Frequently asked questions